Lataa...
Selectivity Conversion of Protease Inhibitory Antibodies
Background: Proteases are one of the largest pharmaceutical targets for drug developments. Their dysregulations result in a wide variety of diseases. Because proteolytic networks usually consist of protease family members that share high structural and catalytic homology, distinguishing them using s...
Tallennettuna:
| Julkaisussa: | Antib Ther |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206439/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tby008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|